IQVIA Holdings Inc banner

IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 158.715 USD -9.41%
Market Cap: $27B

During the last 3 months IQVIA Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 33% over this period (open performance analysis).

The last transaction was made on Dec 18, 2025 by Bousbib Ari , who sold 8.1m USD worth of IQV shares.

Last Transactions:
Bousbib Ari
$-8.1m
Sherbet Eric
$-878.8k
Bousbib Ari
$-174.1k
Sherbet Eric
$-1.1m
Cherofsky Keriann
$-105.1k
Danhakl John G
$+255.7k
Sherbet Eric
$-320.2k
Bousbib Ari
$-4.1m
Staub W Richard
$-2.2m
Knightly Kevin C
$-1.6m
Sherbet Eric
$-241.5k
Knightly Kevin C
$-804.2k
Knightly Kevin C
$-1.5m
Panagos Constantinos
$-4.2m
Knightly Kevin C
$-1.2m
Knightly Kevin C
$-198.7
Knightly Kevin C
$-377.8k
Sherbet Eric
$-230k
Danhakl John G
$+2.7m
Connaughton John
$-145.8m
Bruehlman Ronald E
$-1k
Bruehlman Ronald E
$+1.1k
Knightly Kevin C
$-1.5m
Bruehlman Ronald E
$+3.2k
Danhakl John G
$+11.2m
Rittenmeyer Ronald A
$-1.7m
Rittenmeyer Ronald A
$-7.1m
Bousbib Ari
$-11.8m
Bousbib Ari
$-7.6m
Bousbib Ari
$-11.2m
Staub W Richard
$-2.2m
Bruehlman Ronald E
$+1.6m
View All Transactions

During the last 3 months IQVIA Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 33% over this period (open performance analysis).

The last transaction was made on Dec 18, 2025 by Bousbib Ari , who sold 8.1m USD worth of IQV shares.

Sold
0-3
months
0 USD
0
3-6
months
9.2m USD
2
6-9
months
0 USD
0
9-12
months
1.2m USD
2
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
0
0 USD

IQVIA Holdings Inc
Insider Trading Chart

IQVIA Holdings Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

IQVIA Holdings Inc
Last Insider Transactions

Global
Insiders Monitor

IQVIA Holdings Inc
Glance View

In the world of healthcare, IQVIA Holdings Inc. emerges as a formidable player, seamlessly blending data analytics with the imperative of human well-being. Born from the merger of IMS Health and Quintiles in 2016, IQVIA stands at the intersection of technology and life sciences, leveraging vast amounts of health-related data to facilitate more informed decisions in drug development and patient care. The company's vast repository consists of a complex tapestry of dynamic insights from around the globe, which it transforms using sophisticated analytical tools. This technical prowess enables IQVIA to offer solutions that span clinical trials, health information services, and advanced analytics, creating substantial value for pharmaceutical and life sciences companies. At the heart of IQVIA’s revenue model lies its ability to provide strategic services that reduce the time and cost associated with the development of new pharmaceuticals. By offering an integrated suite of services from the initial phases of drug research to post-market monitoring, IQVIA assists its clients in navigating regulatory landscapes and commercializing their products effectively. Its expansive technological infrastructure does not just aid in drug development but also enhances patient engagement, creating digital pathways for more personalized healthcare solutions. Thus, IQVIA earns its keep by not only selling information but also by offering transformative insights that sharpen the competitive edge for its clients in the ever-evolving healthcare sector.

IQV Intrinsic Value
262.589 USD
Undervaluation 40%
Intrinsic Value
Price $158.715

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett